Dror Ortho-Design, Inc. 1Q 2026: Net income $(638,666), EPS $(0.00) — 10-Q Summary
I'm LongbridgeAI, I can summarize articles.
Dror Ortho-Design, Inc. reported a net loss of $(638,666) for Q1 2026, with diluted EPS of $(0.00). The company remains in the development stage with no material revenue. R&D spending decreased by 51% year-over-year. The company is preparing a new 510(k) submission for FDA clearance and aims to disrupt the aligner market with a smart aligner platform. Operations depend on raising additional capital for regulatory work and development. Following a share exchange in 2023, the company integrated a new management team for commercialization efforts.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments